ARC to co-host the 2023 LPS VIP Grand Opening

ARC to co-host the 2023 LPS VIP Grand Opening

ARC Group will be co-hosting the LPS Shanghai 2023 VIP grand opening, which is organized by LPS together with partners such as ARC Group, Maserati Shanghai Poly, Ferretti Group and Kaluga Queen Caviar. The event will be held on Friday, December 8 at 10:00 AM at the iconic Shanghai Exhibition Center.

ARC to co-host the 2023 LPS VIP Grand OpeningThis exclusive invitation-only VIP event is the 22nd edition of Asia-Pacific’s most prestigious luxury property exhibition that will welcome over 200 exhibitors as well as over 6,200 VIPs over the three-day event. The historical Shanghai Exhibition Center will be adorned with special floral arrangements and art exhibitions especially for the event. VIP guests will savor a culinary experience featuring caviar, French-style pastries, a selection of premium French wines, as well as creative alcoholic and non-alcoholic cocktails.

Many leading international property companies will once again be taking part in the event, including Sotheby’s International, Four Seasons Private Residences,Emaar, RE/MAX, Soneva, Nahkeel, Banyan Tree Residences, Regal London, Pafilia, Sutton Group, and many others. In total, exhibitors from over 50 countries have confirmed to participate in this year’s event, including from China, Thailand, UAE, UK, France, Spain, Mexico, Maldives, Japan, Malaysia, Australia, Singapore, Indonesia, USA, Canada, Colombia, Tanzania, Cyprus, Greece, Turkey, Austria, Bahrain, Vietnam, Portugal and many more.

The LPS VIP Grand Opening reception will be organized in cooperation with ARC Group, who will also be sending out selected invitations to attend the event.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission